ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaarBiogen Switzerland AG
Biogen Switzerland AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Biogen is the research, development and production of medicines, in particular large and small molecular therapeutics, as well as biosimilars, with a focus on the treatment of severe diseases such as neurology, neuropsychiatry, immunology and rare diseases.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Biogen Switzerland AG

✓ Offered7
Medicines
Medicines for neurology, immunology and rare diseases, including therapies for multiple sclerosis, Alzheimer’s disease, SMA, ALS, Friedreich ataxia, lupus and kidney disease.
Clinical Trials
Clinical trials in neurologic and immunologic diseases to test the safety and effectiveness of investigational therapies, with participation from patients, families and healthcare professionals.
Pipeline
Development pipeline of potential therapies in neurology, immunology and rare diseases, including programs for Alzheimer’s disease, multiple sclerosis, lupus, Friedreich ataxia, SMA, ALS and kidney disease.
Early Access to Therapies
Early access to investigational or not-yet-approved therapies for serious diseases when no suitable alternative exists and local legal requirements are met.
Biopharmaceutical Manufacturing
Development, manufacturing and delivery of medicines with quality control, process development, global supply chain expertise and production sites in the U.S. and Switzerland.
Medical Information
Medical information for healthcare professionals, patients and caregivers on products and benefit-risk questions, via phone, email and a medical information portal.
Partnerships and Licensing
Partnerships, collaborations, acquisitions and licensing models to develop and commercialize new medicines in neurology, immunology, nephrology and rare diseases.
Trust & reputation

ranQ Trust Score of Biogen Switzerland AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Biogen Switzerland AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Biogen Switzerland AG scores 94.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.90.07%
Biogen Switzerland AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Biogen Switzerland AG scores 70.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.40.04%
Qualifications+0.00

Biogen Switzerland AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

October 25, 2024Media
Biotech-Konzern Biogen entlässt erneut Mitarbeiter in Baar ZG
blick.ch
May 29, 2017Media
Pharmafirma am Jurasüdfuss - Gigantisch: Biogen-Neubau in Luterbach aussen fertig gebaut
srf.ch
July 1, 2015Media
Aargau Solothurn - Biogen bringt neues Leben auf die Industriebrache
srf.ch

Knowledge

No knowledge articles yet

Once Biogen Switzerland AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Biogen Switzerland AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Biogen Switzerland AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Biogen Switzerland AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuhofstrasse 30
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-108.460.535
Founded
1996 · 30 years
Last commercial register change
July 9, 2026
Employees
51 to 100
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AP
    Alexion Pharma GmbH
    Baar
    FS
    FyoniBio SA
    Baar
    CL
    Centenara Labs AG
    Baar
    AS
    Alnylam Switzerland GmbH
    Zug
    AI
    Apellis International GmbH
    Zug
    JP
    Jazz Pharmaceuticals Switzerland GmbH
    Zug
    ME
    Meditrial Europe AG
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug